Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

Patients with atrial fibrillation (AF) are at increased risk for coronary artery disease (CAD). After percutaneous coronary intervention (PCI), the antithrombotic therapy consists of a combination of anticoagulant and antiplatelet agents to reduce the ischemic and thromboembolic risk, at the cost of...

Descripción completa

Detalles Bibliográficos
Autores principales: De Luca, Leonardo, Mistrulli, Raffaella, Veneziano, Francesco Antonio, Grigioni, Francesco, Volpe, Massimo, Musumeci, Francesco, Gabrielli, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836736/
https://www.ncbi.nlm.nih.gov/pubmed/35159964
http://dx.doi.org/10.3390/jcm11030512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836736/
https://www.ncbi.nlm.nih.gov/pubmed/35159964
http://dx.doi.org/10.3390/jcm11030512

Ejemplares similares